Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using 177Lu-iPSMA and 177Lu-DOTATOC: Experience after 905 Treatment Doses.
Pharmaceutics. 2023 Jul 20;15(7):1988. doi: 10.3390/pharmaceutics15071988.
Pharmaceutics. 2023.
PMID: 37514174
Free PMC article.
Targeted Endoradiotherapy with Lu2O3-iPSMA/-iFAP Nanoparticles Activated by Neutron Irradiation: Preclinical Evaluation and First Patient Image.
Luna-Gutiérrez M, Ocampo-García B, Jiménez-Mancilla N, Ancira-Cortez A, Trujillo-Benítez D, Hernández-Jiménez T, Ramírez-Nava G, Hernández-Ramírez R, Santos-Cuevas C, Ferro-Flores G.
Luna-Gutiérrez M, et al.
Pharmaceutics. 2022 Mar 27;14(4):720. doi: 10.3390/pharmaceutics14040720.
Pharmaceutics. 2022.
PMID: 35456554
Free PMC article.
Item in Clipboard
225Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins.
Hernández-Jiménez T, Ferro-Flores G, Morales-Ávila E, Isaac-Olivé K, Ocampo-García B, Aranda-Lara L, Santos-Cuevas C, Luna-Gutiérrez M, De Nardo L, Rosato A, Meléndez-Alafort L.
Hernández-Jiménez T, et al.
Molecules. 2022 Mar 27;27(7):2156. doi: 10.3390/molecules27072156.
Molecules. 2022.
PMID: 35408554
Free PMC article.
Item in Clipboard
Cite
Cite